Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanostart portfolio company ItN Nanovation AG publishes financial figures for 2010

Abstract:
Nanostart (OTCQX: NASRY) portfolio company ItN Nanovation AG (FSE: I7N) published its figures for the 2010 fiscal year today. The company generated revenue of €2.7 million. After adjustment for a division that has since been sold, revenue of €2.4 million was generated in the previous fiscal year. A comparative assessment adjusted for the revenue of this product group, which is no longer manufactured for strategic reasons, shows an 8.5% year-on-year increase in revenue. Revenue of €4.5 million was attained in 2009. As a result of rigorous cost discipline, earnings from operating activities were improved from €-5.9 million to €-5.3 million in 2010. At €-5.8 million, the net loss for the year also proved to be slightly more positive than the prior-year figure of €-6.1 million.

Nanostart portfolio company ItN Nanovation AG publishes financial figures for 2010

Frankfurt am Main / Saarbrücken | Posted on April 21st, 2011

In particular, ItN Nanovation achieved key strategic aims in the past fiscal year and made significant progress, especially in terms of market penetration of its ceramic flat membrane solutions, CFM systems. In the third quarter of 2010, a drinking water plant in Saudi Arabia was industrially fitted with CFM systems for the first time, replacing the conventional solution. On the basis of the superior product characteristics, ItN Nanovation soon received an additional follow-up order in the same plant complex. ItN Nanovation also carried out preparatory work in the region for a joint venture with a Saudi Arabian investor and a consortium of German industrial investors. This is set to be finalized in 2011, with a positive earnings effect of around USD 2.35 million.

Income of more than €6.3 million is likely to be generated in 2011, chiefly as a result of the income from CFM systems. A substantial increase in earnings is also planned. To ensure resources for further business development, the company is currently carrying out a cash capital increase, which ItN Nanovation expects to raise €11 million gross.

####

About Nanostart AG
Nanostart AG (OTCQX: NASRY), is the world’s leading nanotechnology investment company. Headquartered in Frankfurt am Main, it invests venture capital in nanotechnology companies in various development phases. Investments are focused on companies in the most innovation-driven segments: cleantech, life sciences and IT/electronics. Through its wholly-owned subsidiary in Singapore, Nanostart invests in nanotechnology companies in Asia in conjunction with the government of Singapore. For more information on the company, please visit www.nanostart.de.

About ItN Nanovation:
ItN Nanovation AG (FSE: I7N) is one of the world’s top nanotechnology companies. It develops innovative ceramic products such as filter systems and coatings for major industrial customers. The company manufactures the necessary nanoscale powder in-house. ItN Nanovation’s filter products can be used for drinking water treatment and wastewater purification, as filters in the drinks industry and to separate oil and water. Nanotechnology-based ceramic coatings are used as protective and catalytic layers in a wide range of applications in various industries, from ovens through aluminum foundries to coal-fired power stations. ItN Nanovation was founded in 2000. The company’s success is based on an extensive patent portfolio combined with in-depth development and application expertise. For more information on the company, please visit www.itn-nanovation.de.

Disclaimer:
This communication does not constitute an offer to sell or a request to submit an offer to buy or subscribe to securities. No initial public offering (IPO) of securities of Nanostart AG is taking place in connection with the listing of shares in the Open Market sub-segment of the Frankfurt Stock Exchange, the “Entry Standard”. This communication does not constitute a securities prospectus. This communication and the information it contains are not meant to be directly or indirectly forwarded to or within Canada, Australia or Japan.

For more information, please click here

Contacts:
Nanostart AG
Dr. Hans Joachim Duerr
Head of Corporate Communication
Goethestrasse 26-28
D-60313 Frankfurt am Main
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 150
email:

Copyright © Nanostart AG

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project